Amarin Corp Plc (AMRN)

[lizzy241]

New Analyses Show Amarin's Vascepa Reduces Ischemic Events in Angioplasty Patients -- Stock Up 5% After-Hours
MT NEWSWIRES 4:55 PM ET 10/15/2020
Symbol Last Price Change
AMRN 5.05down +0.1 (+2.0202%)
QUOTES AS OF 04:00:00 PM ET 10/15/2020
04:55 PM EDT, 10/15/2020 (MT Newswires) -- Amarin(AMRN) said on Thursday new analyses showed that its Vascepa drug reduced ischemic events in patients who had prior percutaneous coronary intervention (PCI), meaning that patients who have undergone angioplasty with stents to open up their blood vessels.

"The findings of benefit in at-risk patients with prior PCI are consistent with previously presented data on overall reductions in first and total coronary revascularization events of 34% and 36%, respectively," said principal investigator Deepak Bhatt.

"The statistically significant substantial benefit in reduced coronary revascularization procedures seen as early as 11 months provides clinicians with a potential additional intervention in a patient population for whom time is of the essence."

Price: 5.28, Change: +0.23, Percent Change: +4.55


MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

©http://www.mtnewswires.com Copyright © 2020 MT Newswires. All rights reserved.